Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (883)	2/26/1999 4:48:00 PM
From: Dr. John M. de Castro	Read Replies (2) \| Respond to of 887

Jim, I don't see SkyePharma as that strong of a company. in fact after having read their portion of the merger agreement, I'm puzzled how they will ever get to profitability. I was also surprised to see that their convertible debentures had a number of characteristics like a floorless convertible. Definitely not the best financing arrangement I've seen. In addition, the short interest increase in SKYEY tends to back up this assertion. I know that at least some of this is a hedge against DEPO shares, but the numbers are striking (17 days to cover). Month Shorts Av.Vol. Ratio 02/99 111,583 6,449 17.30 01/99 89,635 3,615 24.80 12/98 62,084 17,388 3.57 11/98 4,015 3,204 1.25 10/98 1,178 2,638 0.45 Maybe we should start a skye thread to discuss this company further. Regards John de C